The invention is about a permanent total artificial heart device that is developed for the patients who are at the end-stage heart failure and included in the heart transplantation program, and which is placed into the ventricles of the patient's heart completely or placed surgically into the space obtained when a piece of ventricle is removed. The device employs “direct drive technology,” technically using the advantages of brushless electric motors. Special-designed engines require quite little energy for the pulsatile blood flow produced by stopping and starting synchronously with the ECG signals. It is about a permanent total artificial heart device system that will offer high quality of life for many years to the patients as it protects the heart valves and heart conduction system, has wireless charging and longer battery life.